Dr. Zsofia K. Stadler

Dr. Zsofia K. Stadler, MD, is a board-certified medical oncologist specializing in gastrointestinal cancers with a focused expertise in hereditary colorectal cancer risk and cancer genetics. She practices at the intersection of oncology and clinical genetics, caring for patients with gastrointestinal malignancies while also running a dedicated genetics clinic offering clinical counseling and genetic testing for individuals with an inherited predisposition to gastrointestinal and other cancers. Working closely with a multidisciplinary team of surgeons, oncologists, gastroenterologists, and radiation therapists, she provides individualized treatment planning that integrates genetic information into both active cancer management and post-treatment surveillance.

Her research centers on identifying novel cancer-susceptibility genes and developing improved screening and prevention strategies for high-risk families. She has studied genetic susceptibility in patients with more than one malignancy through funding from the National Institutes of Health, and her work on the genetic causes of early-onset cancer has earned significant recognition. She received an American Society of Clinical Oncology Career Development Award and was selected for a Clinical Investigator Award from the Damon Runyon Cancer Research Foundation, both honoring her contributions to understanding the hereditary basis of cancer.

Dr. Stadler is an active member of the American Society of Clinical Oncology, where she recently served as chair of its education committee on cancer genetics, reflecting her commitment to advancing the field through education and leadership. Her integrated approach to oncology and genetics allows her to help patients and families understand their cancer risk, make informed treatment decisions, and access appropriate surveillance following cancer care. Through her clinical practice, research, and professional service, she continues to shape how hereditary cancer risk is identified and managed in patients with gastrointestinal malignancies.